Your session is about to expire
← Back to Search
Other
C-KAD Ophthalmic Solution for Asteroid Hyalosis
Phase 2
Waitlist Available
Research Sponsored by Chakshu Research, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of asteroid hyalosis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180
Awards & highlights
Study Summary
To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 180
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reduction in the number of asteroid bodies
Side effects data
From 2015 Phase 4 trial • 157 Patients • NCT020033916%
Ocular hyperaemia
5%
Eye pruritus
2%
Nasopharyngitis
2%
Dry eye
1%
Acute tonsillitis
1%
Conjunctivitis allergic
1%
Eyelids pruritus
1%
Blepharal pigmentation
1%
Pharyngitis
1%
Eye irritation
1%
Cataract
1%
Arthritis
1%
Hypersensitivity
1%
Eye pain
1%
Ocular surface disease
100%
80%
60%
40%
20%
0%
Study treatment Arm
DuoTrav
Beta-blocker
Trial Design
1Treatment groups
Experimental Treatment
Group I: C-KAD Ophthalmic SolutionExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
C-KAD Ophthalmic Solution
2007
N/A
~20
Find a Location
Who is running the clinical trial?
Chakshu Research, Inc.Lead Sponsor
3 Previous Clinical Trials
173 Total Patients Enrolled
Ira Wong, MDStudy DirectorChakshu Research, Inc.
2 Previous Clinical Trials
92 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger